Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Jan;39(1):77-78.
doi: 10.1097/DBP.0000000000000513.

ADHD Medication Adherence in College Students-A Call to Action for Clinicians and Researchers: Commentary on "Transition to College and Adherence to Prescribed Attention Deficit Hyperactivity Disorder Medication"

Affiliations
Comment

ADHD Medication Adherence in College Students-A Call to Action for Clinicians and Researchers: Commentary on "Transition to College and Adherence to Prescribed Attention Deficit Hyperactivity Disorder Medication"

Tanya E Froehlich. J Dev Behav Pediatr. 2018 Jan.

Erratum in

No abstract available

PubMed Disclaimer

Comment on

Similar articles

References

    1. DuPaul GJ, Weyandt LL, O'Dell SM, Varejao M. College students with ADHD: current status and future directions. J Atten Disord. 2009;13(3):234–250. - PubMed
    1. Hack S, Chow B. Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol. 2001;11(1):59–67. - PubMed
    1. Perwien A, Hall J, Swensen A, Swindle R. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder. J Manag Care Pharm. 2004;10(2):122–129. - PMC - PubMed
    1. Faraone SV, Biederman J, Zimmerman B. An analysis of patient adherence to treatment during a 1-year, open-label study of OROS methylphenidate in children with ADHD. J Atten Disord. 2007;11(2):157–166. - PubMed
    1. Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. CNS Drugs. 2003;17(2):117–131. - PubMed